phone: +265(0)883699070/ +31(0)616193631 35 Abstract 36 37 Introduction: Iron deficiency is a treatable cause of severe anaemia in low-and-middle-38 income-countries (LMIC). Diagnosing it remains challenging as peripheral blood markers 39 poorly reflect bone-marrow iron deficiency (BM-ID), especially in the context of HIV-40 infection.
142
Methods| Infections
143
HIV infection was confirmed using two point-of-care antibody tests (Unigold® and 144 Determine®). Different types and severity of on-going infections were evaluated.
145
Including; HIV: CD4 counts ≤200 cells/mm 3 and/or viral load >1000 copies/ml. Malaria: 146 presence of malaria parasites in a thick blood film assessed by light microscopy. 
165
The data were analysed using Stata (version 12) (STATA Corp. LP, Texas, TX, USA).
166
Baseline characteristics were compared between BM-ID and non-deficient patients using the common peripheral blood markers (0.545), the sensitivity and specificity using the 201 common cut off of 83fL were 42% and respectively 67%. The use of hepcidin to detect 202 BM-ID resulted in an AUC ROC 0.593. We stratified the analysis for hepcidin according to 203 gender; the AUC ROC for men and women was 0.767 and 0.490 respectively. The optimal hepcidin concentration for the detection of BM-ID was ≤7 ng/ml; sensitivity 67% & 205 specificity 67%. In males the optimum cut off was ≤6 ng/ml (sensitivity 80%; specificity 206 78%); whilst for women this was ≤7 ng/ml (sensitivity 60%; specificity 61%, figure 1). The 
Discussion

243
In this study on hepcidin and conventional markers to detect BM-ID in severely anaemic HIV-244 infected patients in Malawi, we found that BM-ID was present in almost half of our patients. In
245
the first study evaluating hepcidin as a marker for BM-ID among severely anaemic HIV-infected 246 adults in such a setting we found that hepcidin had the highest AUC ROC 0.593 amongst all 247 peripheral markers and therefore was the best marker to use for detecting BM-ID. MCV was 248 found to be the best conventional peripheral blood marker for BM-ID. As the MCV is 249 commonly provided as part of routine full blood counts this marker may be of some use in 
269
Irrespective of the cause, the role of iron supplementation to prevent and treat severe anaemia 270 appears to have gained importance.
271
Our results concerning the accuracy of peripheral blood markers to detect BM iron 272 deficiency indicate that it is not easy to reliably detect those with deficient BM iron stores,
273
which corroborates with previous studies (8, 9) . Hepcidin, a specific hormone in metabolising 274 iron, did perform slightly better than conventional markers, but remained far from good or 275 even perfect. Additionally, hepcidin is a key player in the absorption of iron and thus may be 276 used to not only select those needing iron but also may predict iron supplementation,
277
response, safety and timing. Hepcidin as a possible marker for BM-ID, has not been evaluated before in this population of severely anaemic HIV-infected adults in Africa. It is not surprising 279 that hepcidin remains from prefect as a marker for BM-ID as we know that hepcidin levels are 
300
Swinkels unpublished data) (37). For this specific patient population, our study thus provides a 301 first and rough estimate for cut off point that are universally applicable by other assays that they 302 are standardized using this same reference material. However, for formal universal use of these 303 cut-off points these values should be confirmed by studies that directly measure samples with a 304 standardized hepcidin method. Additionally, hepcidin optimal cut-offs were more sensitive and 
